Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Payables (2016 - 2025)

Metlife (MET) has 17 years of Payables data on record, last reported at $378.0 million in Q3 2025.

  • For Q3 2025, Payables changed N/A year-over-year to $378.0 million; the TTM value through Sep 2025 reached $378.0 million, changed N/A, while the annual FY2024 figure was $465.0 million, 290.76% up from the prior year.
  • Payables reached $378.0 million in Q3 2025 per MET's latest filing, down from $465.0 million in the prior quarter.
  • Across five years, Payables topped out at $465.0 million in Q4 2024 and bottomed at $119.0 million in Q4 2023.
  • Average Payables over 5 years is $266.7 million, with a median of $251.0 million recorded in 2021.
  • Peak YoY movement for Payables: plummeted 50.13% in 2022, then soared 290.76% in 2024.
  • A 5-year view of Payables shows it stood at $341.0 million in 2021, then tumbled by 48.68% to $175.0 million in 2022, then crashed by 32.0% to $119.0 million in 2023, then skyrocketed by 290.76% to $465.0 million in 2024, then decreased by 18.71% to $378.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $378.0 million in Q3 2025, $465.0 million in Q4 2024, and $390.0 million in Q2 2024.